We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 56,717

Opportunity - FDA encouraging manufacture and distribution of new generic drugs
  • Innofy
  • USA
  • July 21 2017

The U.S. Food and Drug Administration (FDA) are desperately seeking to increase competition for prescription drugs. The reasons for this are of no


Michigan Court Excludes Expert Testimony from Treater and Grants Summary Judgment
  • Dechert LLP
  • USA
  • July 20 2017

Usually when we are talking about Michigan, it's to praise the Michigan Products Liability Act which cuts off civil liability for drug manufacturers


Will Tort Reform Affect Nursing Home Care?
  • Stark & Stark
  • USA
  • July 20 2017

The latest tort reform measure, H.R. 1215, the Protecting Access to Care Act of 2017, would place caps on medical malpractice damages, limit attorney


Massachusetts Supreme Judicial Court Creates Employer Obligation to Accommodate Employees Using Medical Marijuana
  • Littler Mendelson PC
  • USA
  • July 19 2017

On July 17, 2017, the Massachusetts Supreme Judicial Court unanimously held that an employee may pursue a disability discrimination claim under state


FDA Creates Uncertainty by Delaying Nutrition Facts Label Compliance
  • Pepper Hamilton LLP
  • USA
  • July 19 2017

Client Alert FDA finalized the terms of the new Nutrition Facts Label in May 2016 and set a compliance deadline of July 26, 2018. The new label


FDA Advisory Committee Recommends Approval of CAR-T Cell Therapy and Two New Biosimilars
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • July 19 2017

The FDA’s Oncologic Drug Advisory Committee (“ODAC”) held a public meeting on Wednesday, July 12, 2017, to consider Novartis’ biologic license


US FDA - no longer "not" cosmetics?
  • Baker McKenzie
  • USA
  • July 19 2017

The Personal Care Products Safety Act bill (PCPS), originally introduced in 2015, has been re-introduced with bipartisan support. Notwithstanding


OIG to Review EHR Incentive Payments to Hospitals
  • Day Pitney LLP
  • USA
  • July 19 2017

A July 18 article in Bloomberg BNA's Health Care Daily Report and other publications, "Health-Care Watchdog to Review Medicaid Opioid Claims,"


Records Management - What’s New
  • Duane Morris LLP
  • USA
  • July 19 2017

Federal and state laws and payers require healthcare providers to create and maintain a whole host of records. Records that are required to be


What IP Diligence is Due
  • Ropes & Gray LLP
  • USA
  • July 19 2017

Intellectual property due diligence can be practiced in a variety of transactional contexts including mergers and acquisitions, licensing, initial